October 07, 2013
A former Celgene Corp. executive on Monday settled with the U.S. Securities and Exchange Commission over allegations he spearheaded a New Jersey-based insider trading network that used confidential information on acquisitions and other corporate developments to generate more than $1.4 million in illegal profits, according to court documents.